Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion type Assertion NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_head.
- NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion description "[Results of these experiments indicate that severity of the articular disease was significantly reduced in the groups of mice treated with CHO/IL-4 or CHO/IL-13 cells encapsulated in HF, compared with control groups receiving CHO/betagal cells encapsulated in HF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_provenance.
- NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion evidence source_evidence_literature NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_provenance.
- NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion SIO_000772 10444273 NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_provenance.
- NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion wasDerivedFrom befree-20140225 NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_provenance.
- NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_assertion wasGeneratedBy ECO_0000203 NP526412.RAX27Yu8WTdPWagW86EQai5fUlpzd-a8YNFncwwT4uRnI130_provenance.